Glutamate acts as a key signal linking glucose metabolism to incretin/cAMP action to amplify insulin secretion.

Glutamate acts as a key signal linking glucose metabolism to incretin/cAMP action to amplify insulin secretion.

Incretins, hormones released by the gut after meal ingestion, are essential for maintaining systemic glucose homeostasis by stimulating insulin secretion. The effect of incretins on insulin secretion occurs only at elevated glucose concentrations and is mediated by cAMP signaling, but the mechanism ...

書誌詳細
主要な著者:	Gheni, G, Ogura, M, Iwasaki, M, Yokoi, N, Minami, K, Nakayama, Y, Harada, K, Hastoy, B, Wu, X, Takahashi, H, Kimura, K, Matsubara, T, Hoshikawa, R, Hatano, N, Sugawara, K, Shibasaki, T, Inagaki, N, Bamba, T, Mizoguchi, A, Fukusaki, E, Rorsman, P, Seino, S
フォーマット:	Journal article
言語:	English
出版事項:	Elsevier 2014

類似資料

Glutamate Acts as a Key Signal Linking Glucose Metabolism to Incretin/cAMP Action to Amplify Insulin Secretion
著者:: Ghupurjan Gheni, 等
出版事項: (2014-10-01)

Stimulatory effect of imeglimin on incretin secretion
著者:: Quan Yingyue, 等
出版事項: (2023-06-01)

Essential roles of aspartate aminotransferase 1 and vesicular glutamate transporters in β-cell glutamate signaling for incretin-induced insulin secretion.
著者:: Naoya Murao, 等
出版事項: (2017-01-01)

Action of incretins on the pancreatic alpha cell
著者:: McCulloch, L, 等
出版事項: (2015)

The journey to understanding incretin systems: Theory, practice and more theory
著者:: Daisuke Yabe, 等
出版事項: (2019-09-01)

Why Are Incretin-Based Therapies More Efficient in East Asians? Perspectives from the Pathophysiology of Type 2 Diabetes and East Asian Dietary Habits
著者:: Daisuke Yabe, 等
出版事項: (2015-11-01)

The integrated incretin effect is reduced by both glucose intolerance and obesity in Japanese subjects
著者:: Akihiro Hamasaki, 等
出版事項: (2024-06-01)

An analysis of intestinal morphology and incretin-producing cells using tissue optical clearing and 3-D imaging
著者:: Tomonobu Hatoko, 等
出版事項: (2022-10-01)

Tumor‐like features of gene expression and metabolic profiles in enlarged pancreatic islets are associated with impaired incretin‐induced insulin secretion in obese diabetes: A study of Zucker fatty diabetes mellitus rat
著者:: Tomohide Hayami, 等
出版事項: (2020-11-01)

Inflammation and Incretins
著者:: Amitabh Hatwal
出版事項: (2012-01-01)

Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1.
著者:: Gromada, J, 等
出版事項: (1998)

The associations of incretin hormone concentration with gestational diabetes mellitus
著者:: Tatiana V. Saprina, 等
出版事項: (2016-05-01)

Incretin Mimetics in the Indian Context: Revisiting Exenatide
著者:: Shambo S Samajdar, 等
出版事項: (2022-08-01)

Pleiotropic effects of incretins
著者:: Vishal Gupta
出版事項: (2012-01-01)

Recent clinical and pharmacological advancements of incretin-based therapy and the effects of incretin on physiology
著者:: Bhaskar Pal, 等
出版事項: (2024-01-01)

Does Incretin Agonism Have Sustainable Efficacy?
著者:: Sok-Ja Janket, 等
出版事項: (2024-11-01)

The Gut Microbiome’s Influence on Incretins and Impact on Blood Glucose Control
著者:: Ajay S. Dulai, 等
出版事項: (2024-11-01)

Incretin hormones as immunomodulators of atherosclerosis
著者:: Nuria eAlonso, 等
出版事項: (2012-09-01)

Understanding the Cardiovascular Effects of Incretin
著者:: Ji Sung Yoon, 等
出版事項: (2011-10-01)

Incretins in patients with rheumatoid arthritis
著者:: Beatriz Tejera-Segura, 等
出版事項: (2017-10-01)

Stimulation of incretin secreting cells
著者:: Ramona Pais, 等
出版事項: (2016-02-01)

Abnormal gut microbiota and impaired incretin effect as a cause of type 2 diabetes mellitus
著者:: T. Y. Demidova, 等
出版事項: (2022-03-01)

Achieving equitable access to incretin-based therapies in cardiovascular care
著者:: Tina K. Reddy, 等
出版事項: (2024-10-01)

Role of fasting duration and weekday in incretin and glucose regulation
著者:: Kim K B Clemmensen, 等
出版事項: (2020-04-01)

Recent advances in incretin-based therapies.
著者:: Russell-Jones, D, 等
出版事項: (2012)

Incretin Effects and Enteral Feed Transitions
著者:: Ummu Kulthum, Jamaludin, 等
出版事項: (2014)

Mechanisms of neuroprotective action of incretin mimetics
著者:: Timur Dmitrievich Vlasov, 等
出版事項: (2016-01-01)

Incretin-based therapy: renal effects
著者:: Anton Ivanovich Korbut, 等
出版事項: (2016-01-01)

Harnessing the Incretin System with Multi-Agonists
著者:: Martin B Whyte, 等
出版事項: (2022-10-01)

Editorial: Incretin agonists in the treatment of obesity
著者:: Xiaodong Sun, 等
出版事項: (2023-08-01)

Symposium 19: Secretagogues: sulfonylureas and incretins
著者:: Víctor Commendatore
出版事項: (2020-11-01)

Insulin and incretin responses to grazing in insulin‐dysregulated and healthy ponies
著者:: Danielle M. Fitzgerald, 等
出版事項: (2019-01-01)

PANCREATIC AND EXTRA-PANCREATIC EFFECTS OF INCRETINS AND PERSPECTIVES FOR STUDYING ENTEROINSULIN HORMONAL SYSTEM DURING GESTATIONAL DISORDER OF CARBOHYDRATE METABOLISM
著者:: T. V. Saprina, 等
出版事項: (2013-06-01)

Incretin-based therapies: new treatments for type 2 diabetes in the new millennium
著者:: Joan Khoo, 等
出版事項: (2009-08-01)

SAVOR-TIMI to DECLARE-TIMI: A review on cardiovascular outcome trials of incretin-modulators and gliflozins
著者:: Awadhesh K Singh, 等
出版事項: (2019-01-01)

Impact of Incretin-Based Therapies on Adipokines and Adiponectin
著者:: Habib Yaribeygi, 等
出版事項: (2021-01-01)

The Impact of Incretin-Based Medications on Lipid Metabolism
著者:: Habib Yaribeygi, 等
出版事項: (2021-01-01)

Incretins today: multiple effects and therapeutic potential
著者:: Oksana V. Tsygankova, 等
出版事項: (2019-03-01)

Anti-atherosclerotic effect of incretin receptor agonists
著者:: Xin Wang, 等
出版事項: (2024-10-01)

Tirzepatide – a new analogue of incretin hormones
著者:: Gabriela Anglart, 等
出版事項: (2023-10-01)